April 15, 2026New England Journal of Medicine
Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial
Key result
Endovascular therapy reduces post-thrombotic syndrome severity vs standard care but increases bleeding risk.
Why the study?
Does endovascular therapy improve post-thrombotic syndrome severity and health-related quality of life in patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction?
Population
Patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction
Comparison
Endovascular therapy vs standard care
Design
Randomized trial
Follow-up
6-month period
Authors
Discussion
Loading...
Member takes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Many patients with PTS suffer in silence because few physicians are aware of this complication or know how to effectively treat it. This study suggests that even severe PTS is, in fact, a treatable condition in many patients.”
“Postthrombotic syndrome is a complicated condition, but it's actually very common. For the purposes of what the patient is experiencing, they do feel better when they get stented, however, that comes clinically at the expense of”
“In addition, both when we were looking at venous symptoms and health, and looking at patient's overall health status, the patients who were stented [had] improved health-related quality of life demonstrated by higher scores on questionnaires. The size of the differences are pretty robust relative to what we know about the scales.”
Overview
May be offered for moderate-severe PTS with iliac obstruction despite bleeding risk; extends evidence where no prior RCTs existed.
Key Points
- To evaluate the effects of endovascular therapy on post-thrombotic syndrome among patients with iliac-vein obstruction.
- Conducted a randomized trial among patients with moderate or severe post-thrombotic syndrome.
- Compared endovascular therapy to standard care.
- Assessed severity of symptoms and health-related quality of life over a 6-month period.
- Endovascular therapy resulted in less severe post-thrombotic syndrome after 6 months.
- Patients reported improved health-related quality of life compared to standard care.
- Increased risk of bleeding was noted with endovascular therapy.
Structured PICO
Does endovascular therapy improve post-thrombotic syndrome severity and health-related quality of life in patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction?
P
Population
Patients with moderate or severe post-thrombotic syndrome and iliac-vein obstruction
I
Intervention
Endovascular therapy
C
Comparator
Standard care
O
Outcome
Severity of post-thrombotic syndrome and health-related quality of life over a 6-month periodpatient reported
Endovascular therapy improves symptoms and quality of life in patients with moderate to severe post-thrombotic syndrome and iliac-vein obstruction at 6 months, though at the cost of increased bleeding risk.
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Cite This Study
Vedantham et al. (2026) studied this question. Endovascular therapy reduced post-thrombotic syndrome severity and improved quality of life versus standard care, but increased bleeding risk in patients with iliac-vein obstruction.